Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$23,698.00

In vitro and in vivo evaluation of equine probiotics

FY 2019-20

Summary
The equine nutraceuticals industry in Canada is the largest and most rapidly growing division of the domestic veterinary supplements sector. The Goal of the current study is to evaluate the in vitro and in vivo impact of a Canadian dietary probiotic ('ProbioPLUS'; Selected Bioproducts Inc; Guelph ON) (PBP) on the equine hind-gut microflora during an antibiotic challenge. The objectives of the current study are: 1) Create an in vitro model of the equine cecum using an anaerobic culture chamber; 2) use the model created in Objective 1 to determine effects of a common equine antibiotic (Sulfadiazine/Trimethoprim; STP) on pH and bacterial metabolite (acetate, propionate and butyrate) production in the presence and absence of a simulated digest of PBP; and 3) evaluate effect of oral antibiotics on fecal microbial profile of horses receiving a diet containing PBP (0 or 66g/day) for 10 days. Objectives 1 and 2 will develop an in vitro simulation of the equine cecal microbial environment, and this model will be used to evaluate the impact of PPB on microbial disruption by antibiotics. Post-mortem cecal fluid from horses will be maintained in a continuous flow anaerobic chamber, and pH, total volatile fatty acids, acetate, propionate, butyrate, lactate and RNA sequencing of microbial populations will be measured. Once established, we will then introduce a common equine antibiotic (Sulfadiazine/Trimethoprim; STP) in the presence or absence of PBP, and determine its effect on the outcome measures described above. Objective 3 will evaluate the effect of oral STP on fecal quality and microbial profile in horses receiving PBP (0 or 66g/day) for 10 days prior to, during, and days following 10 days of STP administration. Antibiotic use in horses is often associated with potentially life-threatening colitis in horses, likely due to a disruption of the gastrointestinal microbiome. This study will provide important new information on the effect of dietary probiotics on the hind-gut microbiota in antibiotic-treated horses, and will determine the value of co-administration of antibiotics and probiotics in horses as well as other veterinary species and humans.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
533783-2018
Name nom
Pearson, Wendy
Department département
Animal Biosciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
23698
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Installment
inst:2 - 2
Partie
2
Nb partie
2
Application title
In vitro and in vivo evaluation of equine probiotics
Keyword
NSERC
Application summary
The equine nutraceuticals industry in Canada is the largest and most rapidly growing division of the domestic veterinary supplements sector. The Goal of the current study is to evaluate the in vitro and in vivo impact of a Canadian dietary probiotic ('ProbioPLUS'; Selected Bioproducts Inc; Guelph ON) (PBP) on the equine hind-gut microflora during an antibiotic challenge. The objectives of the current study are: 1) Create an in vitro model of the equine cecum using an anaerobic culture chamber; 2) use the model created in Objective 1 to determine effects of a common equine antibiotic (Sulfadiazine/Trimethoprim; STP) on pH and bacterial metabolite (acetate, propionate and butyrate) production in the presence and absence of a simulated digest of PBP; and 3) evaluate effect of oral antibiotics on fecal microbial profile of horses receiving a diet containing PBP (0 or 66g/day) for 10 days. Objectives 1 and 2 will develop an in vitro simulation of the equine cecal microbial environment, and this model will be used to evaluate the impact of PPB on microbial disruption by antibiotics. Post-mortem cecal fluid from horses will be maintained in a continuous flow anaerobic chamber, and pH, total volatile fatty acids, acetate, propionate, butyrate, lactate and RNA sequencing of microbial populations will be measured. Once established, we will then introduce a common equine antibiotic (Sulfadiazine/Trimethoprim; STP) in the presence or absence of PBP, and determine its effect on the outcome measures described above. Objective 3 will evaluate the effect of oral STP on fecal quality and microbial profile in horses receiving PBP (0 or 66g/day) for 10 days prior to, during, and days following 10 days of STP administration. Antibiotic use in horses is often associated with potentially life-threatening colitis in horses, likely due to a disruption of the gastrointestinal microbiome. This study will provide important new information on the effect of dietary probiotics on the hind-gut microbiota in antibiotic-treated horses, and will determine the value of co-administration of antibiotics and probiotics in horses as well as other veterinary species and humans.